The acute effect of inhaled salbutamol and ipratropium on microvascular function

K. Chauhan (London, United Kingdom), H. Al-Rubaye (London, United Kingdom), M. Arzim (London, United Kingdom), V. Osman (London, United Kingdom), E. Baker (London, United Kingdom), H. Fok (London, United Kingdom), S. Ruickbie (London, United Kingdom), D. Burrage (London, United Kingdom)

Source: International Congress 2018 – Basic pharmacology
Session: Basic pharmacology
Session type: Thematic Poster
Number: 1062
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
K. Chauhan (London, United Kingdom), H. Al-Rubaye (London, United Kingdom), M. Arzim (London, United Kingdom), V. Osman (London, United Kingdom), E. Baker (London, United Kingdom), H. Fok (London, United Kingdom), S. Ruickbie (London, United Kingdom), D. Burrage (London, United Kingdom). The acute effect of inhaled salbutamol and ipratropium on microvascular function. 1062

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Comparison of nebulized ipratropium bromide with salbutamol versus salbutamol alone in acute asthma exacerbation in children
Source: Eur Respir J 2004; 24: Suppl. 48, 167s
Year: 2004

Cardiopulmonary effects of inhaled ipratropium bromide and its combination with fenoterol in patients with bronchial asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 58s
Year: 2002

High doses inhaled salbutamol by MDI in patients with acute bronchial asthma and its cardiopulmonary effects
Source: Annual Congress 2009 - Aspects of uncontrolled asthma
Year: 2009

Effect of montelukast or salmeterol added to inhaled fluticasone on response to albuterol in children with exercise-induced bronchoconstriction
Source: Annual Congress 2009 - Drug treatment of childhood asthma: the controversies and the issues
Year: 2009

Acute protection against exercise-induced bronchoconstriction by formoterol, salmeterol and terbutaline
Source: Eur Respir J 2002; 19: 865-871
Year: 2002



The effect of inhaled budesonide and formoterol on bronchial remodeling in young asthmatics
Source: Eur Respir J 2006; 28: Suppl. 50, 208s
Year: 2006

Effects of procaterol or salmeterol added to maintenance tiotropium therapy on small airway functions in COPD patients
Source: Annual Congress 2010 - COPD: management
Year: 2010


Effect of budesonide/formoterol, budesonide and terbutaline on exercise-induced bronchoconstriction in mild intermittent asthma
Source: Annual Congress 2011 - Asthma management and response
Year: 2011

Reversing acute bronchoconstriction in asthma: the effect of bronchodilator tolerance after treatment with formoterol
Source: Eur Respir J 2001; 17: 368-373
Year: 2001



Nebulized formoterol improves airway function in COPD subjects receiving maintenance tiotropium
Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of asthma
Year: 2008

The combination therapy with inhaled tiotropium bromide and transdermal tulobuterol in COPD improves the peripheral airway function
Source: Annual Congress 2010 - Bronchodilator treatment for asthma and COPD
Year: 2010

Effects of salmeterol, formoterol and placebo on pulmonary function and symptom recovery after histamine provocation in mild asthmatics
Source: Eur Respir J 2004; 24: Suppl. 48, 710s
Year: 2004

The acute effect of inhaled salbutamol and ipratropium on aortic stiffness and pressure wave reflection
Source: International Congress 2018 – Studies on the mechanisms underlying airway disease
Year: 2018

High doses of inhaled formoterol have less systemic effect in asthmatic children than high doses of inhaled terbutaline
Source: Eur Respir J 2003; 22: Suppl. 45, 534s
Year: 2003

COPD: Comparison of bronchodilator responsiveness with glycopyrronium and salbutamol
Source: International Congress 2019 – COPD clinical trials: inhaled and oral therapies
Year: 2019


Attenuation of exercise-induced bronchoconstriction with montelukast or salmeterol added to inhaled fluticasone in children
Source: Annual Congress 2009 - Drug treatment of childhood asthma: the controversies and the issues
Year: 2009

Safety of formoterol Turbuhaler(R) at cumulative dose of 90 {micro}g in patients with acute bronchial obstruction
Source: Eur Respir J 2001; 18: 928-934
Year: 2001



Pharmacokinetic differences between inhaled treprostinil and inhaled iloprost in severe pulmonary hypertension
Source: Eur Respir J 2004; 24: Suppl. 48, 109s
Year: 2004

Effect of add-on montelukast to inhaled corticosteroids on excessive airway narrowing in adult asthmatics
Source: Annual Congress 2009 - Aspects of clinical asthma
Year: 2009

Protective effect of inhaled glucocorticosteroid and long-acting beta2-agonist combination on COPD model
Source: Virtual Congress 2021 – Developments in biomarkers and treatment strategies for chronic lung diseases
Year: 2021